ketamine for depression
k

Johnson & Johnson’s $1.7 Billion Drug Success Signals Growth in Psychedelic Medicine Market

Johnson & Johnson’s Spravato, a nasal spray derived from ketamine, has reached blockbuster status with annual sales exceeding $1 billion. Approved in 2019 for...

Popular

Analyzing the Economic Value and Job Market Relevance of University Degrees

The financial return on a university degree is facing...

Europe Prepares for Another Heatwave

Southern and central European countries are preparing for elevated...

Japanese Yen Approaches 160 Against US Dollar Amid Potential Currency Intervention

The Japanese yen has weakened significantly, approaching the key...

US Treasury Yields Projected to Rise Next Year

U.S. Treasury yields are projected to trend significantly higher...
spot_imgspot_imgspot_img
spot_imgspot_imgspot_imgspot_img